Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.

NCT00223938 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

112

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated because of significant enrollment challenges

Conditions

Anemia

Interventions

DRUG: Oral Iron
DRUG: sodium ferric gluconate
DRUG: sodium ferric gluconate

Sponsor

Sanofi